TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Regina Barzilay is a School of Engineering Distinguished Professor of AI & Health in the department of computer science and the AI faculty lead at MIT Jameel Clinic. She develops machine learning ...

Avner Schlessinger, PhD, right, working with his lab researchers at Mount Sinai AI Small Molecule Drug Discovery Center in New York City. [Mount Sinai] Most breakthrough discoveries are made based on ...

New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...

Nvidia formed a $1B partnership with Eli Lilly to develop a co-innovation AI lab for drug discovery. The collaboration expands Nvidia’s BioNeMo platform into healthcare to transform drug discovery ...